Where is OBIO's headquarters located?

OBIO's headquarters is located in Toronto (Canada).

How big is OBIO's investment team?

OBIO has a team of 18, including 7 partners.

How many companies has OBIO invested in?

OBIO has invested in 3 companies, including MY01 & ForceN.

Which companies has OBIO invested in lately?

Tenomix & ForceN are the latest investments by OBIO.

OBIO - 2026 Investor Profile, Portfolio, Team & Investment Trends

OBIO, an accelerator and incubator program founded in 2009, is based in Toronto, Canada. With a presence in 2 countries, it has supported around 3 startups in sectors like High Tech, Life Sciences. Most notable companies in its portfolio are MY01, ForceN and Tenomix. The program is backed by a team of 18 people who primarily support Seed startups based in Canada. Its latest investment was a $1.47M Seed round in Tenomix on Mar 05, 2024.

Key Metrics

Founded Year

2009

Location

Toronto, Canada

Portfolio Companies

MY01, ForceN & 1 more

Sectors of Investment

High Tech, Life Sciences & 2 more

Stages of Investment

Seed

Locations of Investment

Canada & Singapore

View OBIO's full profile

OBIO has a portfolio of 3 companies. Their most notable investments include MY01 and ForceN.Their portfolio spans across Canada and Singapore. They have invested in High Tech, Life Sciences, HealthTech and 1 other sectors, across stages such as Seed stage. Here is the list of all investments by OBIO:

1. MY01

AI-powered medical device for the detection of compartment syndrome. MY01 is the device based on digital micro sensing technology to measure a patient’s intracompartmental pressure up. It offers a mobile app that enables de-identified storage of data on cloud for retrieval after the episode of care.

Key facts about MY01

Founded Year: 2015
Location: Singapore (Singapore)
Stage: Series A
Total Funding till date: $12.6M
Employee Count: 48 as on Aug 31, 2026
Investors: Fondaction, Desjardins and 4 Others
Latest Funding Round: Series A, Aug 20, 2023, $*****
Highlight: Editors' Pick

2. ForceN

Provider of force sensing and haptic force control and simulation solutions for robots. It includes an array of sensors integrated with an electronics module that calibrates, measures, and converts the sensing array signals to noise-free force measurements. It can be used to provide a solution for manufacturing, surgical robots, industrial robots, and defense.

Key facts about ForceN

Founded Year: 2015
Location: Toronto (Canada)
Stage: Series A
Total Funding till date: $6.59M
Employee Count: 46 as on Aug 31, 2026
Investors: Brightspark Ventures, NorthSpring Capital Partners and 11 Others
Latest Funding Round: Series A, Apr 23, 2024, $*****
Highlight: Editors' Pick

3. Tenomix

Developer of cancer screening device for pathologists. The company's product Lymphonator, a bench-top robotic scanning device that guides the hospital's pathology team in lymph node identification in surgically removed colorectal cancer tissues.

Key facts about Tenomix

Founded Year: 2021
Location: London (Canada)
Stage: Seed
Total Funding till date: $1.47M
Employee Count: 10 as on Aug 31, 2026
Investors: OBIO
Latest Funding Round: Seed, Mar 05, 2024, $*****

OBIO has invested in 3 companies over the last 7 years, with an average of 0 new investment annually in the last 5 years. Its most recent first time investment was in Tenomix.

View all investments by OBIO

OBIO has made 2 investments in Seed stage with an average round size of $987K.

View all investments by OBIO

OBIO has a diverse portfolio, with companies operating in the High Tech, Industrial Goods and Manufacturing and Life Sciences. Notably, it has invested in 3 Enterprise (B2B) companies, 3 Tech companies, 3 Tech hardware companies and 1 company focusing on Software.

Here are OBIO's investments by sector:

Sector	No. of Investments
High Tech	1
Industrial Goods and Manufacturing	1
Life Sciences	1

Note: We have considered here, only first round of investments

View all investments by OBIO

OBIO has made most investments in Canada (2).

View all investments by OBIO

OBIO has not made any investment in 2026 so far.

Here are the most recent investments by OBIO:

Filter this list

Date	Company	Location	Round Details	Round Amount	Co-Investors
Mar 05, 2024	Tenomix	Canada	Seed	3095	-
May 24, 2019	ForceN	Canada	Seed	6910	NorthSpring Capital Partners ... [+3]

See more recent investments made by OBIO

OBIO has a team of 18 members including 7 Partners and 6 Principals located in Canada and United States. OBIO's team does not sit on the board of any company as of now.

Here is a list of top team members in OBIO:

Name	Designation	Location	Board Memberships	Contact Details
M Cynthia Goh	Partner	Toronto	-	-
Mark Steedman	Partner	Toronto	-	-
Michael Cloutier	Partner	Toronto	-	-
Daniel Billen	Partner	Westlake Village	-	-
Adam Buckley	Partner	Cambridge	-	-
John Jordan	Partner	Canada	-	-
Jung-Kay Chiu	Partner	Canada	-	-
Julia Summerhill	Principal	Canada	-	1 Email
Doriane Rey	Principal	Canada	-	1 Email
Christina Yeh	Principal	Canada	-	1 Email
Parnian Tajbakhsh	Principal	Canada	-	1 Email

View team details of OBIO

Over the past 7 years, 9 investors have co-invested in OBIO's portfolio companies. This includes only funds.

Top Co-investors of OBIO: 4 investors entered a company along with OBIO. These include investors like NorthSpring Capital Partners (1 company).
Invested after OBIO: A total of 5 investors have invested in OBIO's portfolio after their investments. Top Investors include Brightspark Ventures (1 company) and BDC (1 company).